Release Date: 22/02/21 13:05 Summary: Notices Received Under S203D & 249D of the Corporations Act Price Sensitive: No Download Document 144.32KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%